Compugen's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Compugen last closed at $2.13 (+0.47%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is 5.7×. Its overall grade ranks 479 of 738 stocks in Healthcare.
About this company
Compugen last closed at $2.13 (+0.47%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 479/738
Valuation grade C+
Related stocks
- Bristol Myers SquibbCustomer
면역항암 후보물질 공동개발·라이선스 파트너 가능성이 큰 대형 제약사
- Takeda PharmaceuticalCustomer
Compugen의 항암 파이프라인과 연계된 글로벌 제약 협업 상대
- Merck & Co.Competitor
면역항암제·종양학 분야에서 Compugen의 개발 방향과 겹치는 대형 경쟁사
About Compugen
- What technical signals does Compugen (CGEN) have?
- Compugen current technical signals: no active technical signal.
- Is Compugen a cup-and-handle pattern?
- No. Compugen has no valid Cup signal right now.
- What published figures are available for Compugen?
- Trailing 12 months PER: 5.7×. Latest quarter PBR: 2.26×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Compugen, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.